Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | folate hydrolase (prostate-specific membrane antigen) 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_128101 | All targets in OG5_128101 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_128101 | All targets in OG5_128101 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_128101 | All targets in OG5_128101 |
Echinococcus multilocularis | n acetylated alpha linked acidic dipeptidase 2 | Get druggable targets OG5_128101 | All targets in OG5_128101 |
Candida albicans | similar to transferrin receptor | Get druggable targets OG5_128101 | All targets in OG5_128101 |
Schistosoma japonicum | ko:K01301 glutamate carboxypeptidase II [EC3.4.17.21], putative | Get druggable targets OG5_128101 | All targets in OG5_128101 |
Schistosoma mansoni | NAALADASE L peptidase (M28 family) | Get druggable targets OG5_128101 | All targets in OG5_128101 |
Candida albicans | hypothetical protein | Get druggable targets OG5_128101 | All targets in OG5_128101 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0033 | 0 | 0.5 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0033 | 0 | 0.5 |
Mycobacterium ulcerans | lipoprotein aminopeptidase LpqL | 0.0045 | 0.0255 | 1 |
Schistosoma mansoni | NAALADASE L peptidase (M28 family) | 0.032 | 0.6146 | 1 |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0033 | 0 | 0.5 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0033 | 0 | 0.5 |
Echinococcus granulosus | endoplasmic reticulum metallopeptidase 1 | 0.0033 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0456 | 0.905 | 0.905 |
Trypanosoma brucei | glutaminyl cyclase, putative | 0.0033 | 0 | 0.5 |
Brugia malayi | Peptidase family M28 containing protein | 0.0033 | 0 | 0.5 |
Echinococcus multilocularis | n acetylated alpha linked acidic dipeptidase 2 | 0.0489 | 0.9745 | 1 |
Brugia malayi | nicalin | 0.0033 | 0 | 0.5 |
Onchocerca volvulus | Glutaminyl cyclase homolog | 0.0033 | 0 | 0.5 |
Toxoplasma gondii | peptidase, M28 family protein | 0.0033 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0033 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0033 | 0 | 0.5 |
Brugia malayi | leucyl aminopeptidase | 0.0033 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0033 | 0 | 0.5 |
Trichomonas vaginalis | Clan MH, family M28, aminopeptidase S-like metallopeptidase | 0.0033 | 0 | 0.5 |
Echinococcus granulosus | glutaminyl peptide cyclotransferase | 0.0033 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable lipoprotein aminopeptidase LpqL | 0.0045 | 0.0255 | 1 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0033 | 0 | 0.5 |
Trypanosoma cruzi | glutaminyl cyclase, putative | 0.0033 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0332 | 0.6401 | 0.6401 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0033 | 0 | 0.5 |
Brugia malayi | FXNA | 0.0033 | 0 | 0.5 |
Onchocerca volvulus | 0.0033 | 0 | 0.5 | |
Leishmania major | glutaminyl cyclase, putative | 0.0033 | 0 | 0.5 |
Onchocerca volvulus | Fxna peptidase homolog | 0.0033 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 0.2 nM | Neuroprotective effect of the compound against ischemic injury with median effective concentrationin in rat | ChEMBL. | 15801825 |
IC50 (binding) | = 0.1 nM | In vitro inhibition of N-acetyl-L-aspartyl-[3H]-L-glutamate binding to Glutamate carboxypeptidase II | ChEMBL. | 15801825 |
Ki (binding) | = 0.1 nM | Binding affinity to NAALADase | ChEMBL. | 23025786 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.